Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021)
Zevra Therapeutics' (ZVRA) quarterly Preferred Dividend Payments came in at $16.9 million in Q2 2021, down 54.87% on a QoQ basis from $37.4 million in Q1 2021.
Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021) Analysis & Trends
Zevra Therapeutics (ZVRA) has 1 years of Preferred Dividend Payments data on file, last reported at $16.9 million in Q2 2021.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $16.9 million in Q2 2021, while the trailing twelve-month figure through Mar 2022 was $16.9 million (down 54.87% YoY) and the FY2021 annual result came in at $54.3 million, changed N/A from the prior year.
- Preferred Dividend Payments slipped to $16.9 million in Q2 2021, from $37.4 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $37.4 million in Q1 2021 to a low of $16.9 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Zevra Therapeutics | 671.75 Mn | 450.18 Mn | 38.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 16.90 Mn |
| Mar 31, 2021 | 37.44 Mn |